Strides Pharma Science Limited

Strides Pharma Science Limited

Share · INE939A01011 (XBOM)
Overview
AI-Powered Analysis
Fundamental Analysis
Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of Strides Pharma Science Limited
No Price
Closing Price XBOM 29.04.2026: 1.054,70 INR
29.04.2026 09:21
Current Prices from Strides Pharma Science Limited
ExchangeTickerCurrencyLast TradePriceDaily Change
XNSE: NSE
NSE
STAR.NS
INR
29.04.2026 09:21
1.054,65 INR
0,70 INR
+0,07 %
XBOM: MSE
MSE
STAR.BO
INR
29.04.2026 09:02
1.054,70 INR
0,75 INR
+0,07 %
Share Float & Liquidity
Free Float 61,50 %
Shares Float 56,69 M
Shares Outstanding 92,17 M
Invested Funds

The following funds have invested in Strides Pharma Science Limited:

Fund
iShares MSCI EM IMI ESG Screened UCITS ETF USD (Dist)
Vol. in million
20,89
Percentage (%)
0,0067 %
Fund
iShares MSCI EM IMI ESG Screened UCITS ETF USD (Acc)
Vol. in million
105,76
Percentage (%)
0,0067 %
Company Profile for Strides Pharma Science Limited Share
Strides Pharma Science Limited develops, manufactures, and sells pharmaceutical products in Africa, Australia, North America, Europe, Asia, India, and internationally. It operates through two segments, Pharmaceutical and Biopharmaceutical. The company offers pharma generics in various forms, such as tablets, hard and soft gelatin capsules, sachets, and liquids, as well as nasal spray, powders, solids, ointments, and creams. It also develops branded generics products for the treatment of chronic therapies, including women's health, central nervous system, cardiovascular, diabetes, dermatology, and probiotics under the Renerve, Unibrol, Combiart, Duotab, and Vitafer brands; and anti-retroviral, anti-malarial, anti-tuberculosis, Hepatitis, and other infectious disease drug segments for institutional business. The company has a strategic partnership with Orbicular Pharmaceutical Technologies Private Limited to develop, manufacture, and commercialize nasal sprays. The company was formerly known as Strides Shasun Limited and changed its name to Strides Pharma Science Limited in July 2018. Strides Pharma Science Limited was incorporated in 1990 and is headquartered in Bengaluru, India.

Company Data

Name Strides Pharma Science Limited
Company Strides Pharma Science Limited
Website https://www.strides.com
Primary Exchange XBOM MSE
ISIN INE939A01011
Asset Class Share
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
CEO Badree Komandur
Market Capitalization 97 Mrd.
Country India
Currency INR
Employees 3,1 T
Address Strides House, 560076 Bengaluru
IPO Date 2004-06-08
Dividends from 'Strides Pharma Science Limited'
Ex-Date Dividend per Share
22.07.2025 4,00 INR
09.09.2024 2,50 INR
04.08.2023 1,50 INR
05.08.2021 2,50 INR
24.07.2020 2,00 INR
19.07.2019 3,00 INR
22.08.2019 12,00 INR
12.09.2018 2,00 INR
07.09.2017 4,50 INR
21.07.2016 4,00 INR

Stock Splits

Date Split
06.12.2024 8000:3329

Ticker Symbols

Name Symbol
MSE STAR.BO
NSE STAR.NS
More Shares
Investors who hold Strides Pharma Science Limited also have the following shares in their portfolio:
BlackRock Emerging Mkts K
BlackRock Emerging Mkts K Fund
CHENGDU PUTIAN TEL. H YC1
CHENGDU PUTIAN TEL. H YC1 Share